Treatment strategies for patients with advanced ovarian cancer undergoing neoadjuvant chemotherapy: interval debulking surgery or additional chemotherapy?
Yutaka YoneokaMitsuya IshikawaTakashi UeharaHanako ShimizuMasaya UnoTakashi MurakamiTomoyasu KatoPublished in: Journal of gynecologic oncology (2020)
Administering 3 additional cycles of chemotherapy followed by debulking surgery exhibited equivalent effects on survival as IDS followed by 3 cycles of postoperative chemotherapy. Preoperative serum CA125 levels of ≤30 U/mL may be a useful predictor of achieving complete surgery.